Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

FDA Grants Breakthrough Device Designation to KidneyIntelX™

May 2, 2019
Provides Priority Regulatory Review of AI-Enabled Diagnostic for Fast-Progressing Kidney Disease NEW YORK, May 2, 2019 /PRNewswire/ --  Renalytix AI plc  (LON: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today that it has been granted
Displaying 91 - 96 of 96